dipyridamole has been researched along with Asymptomatic Conditions in 6 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Data from one randomised controlled trial showed no significant difference in benefit with aspirin versus placebo in asymptomatic carotid stenosis, but it is still reasonable to recommend aspirin (81-325 mg daily) for prevention of vascular events in these patients." | 5.01 | Optimal Antiplatelet Therapy in Moderate to Severe Asymptomatic and Symptomatic Carotid Stenosis: A Comprehensive Review of the Literature. ( de Borst, GJ; Halliday, A; Hamilton, G; Kakkos, S; McCabe, DJH; Murphy, SJX; Naylor, AR; Ricco, JB; Sillesen, H; Vega de Ceniga, M, 2019) |
| "We enrolled 129 patients with true RHTN regularly followed in our specialty hypertension clinic and evaluated then by resting and dipyridamole pharmacological stress myocardial perfusion scintigraphy." | 3.81 | Predictors of silent myocardial ischemia in resistant hypertensive patients. ( Barbaro, NR; Calhoun, DA; de Faria, AP; Fontana, V; Modolo, R; Moreno, H; Nascimento, BB; Paganelli, MO; Ramos, CD; Sabbatini, AR, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Pezel, T | 1 |
| Hovasse, T | 1 |
| Kinnel, M | 1 |
| Unterseeh, T | 1 |
| Champagne, S | 1 |
| Toupin, S | 1 |
| Garot, P | 1 |
| Sanguineti, F | 1 |
| Garot, J | 1 |
| Murphy, SJX | 1 |
| Naylor, AR | 1 |
| Ricco, JB | 1 |
| Sillesen, H | 1 |
| Kakkos, S | 1 |
| Halliday, A | 1 |
| de Borst, GJ | 1 |
| Vega de Ceniga, M | 1 |
| Hamilton, G | 1 |
| McCabe, DJH | 1 |
| Modolo, R | 1 |
| de Faria, AP | 1 |
| Paganelli, MO | 1 |
| Sabbatini, AR | 1 |
| Barbaro, NR | 1 |
| Nascimento, BB | 1 |
| Ramos, CD | 1 |
| Fontana, V | 1 |
| Calhoun, DA | 1 |
| Moreno, H | 1 |
| Lièvre, MM | 1 |
| Moulin, P | 1 |
| Thivolet, C | 1 |
| Rodier, M | 1 |
| Rigalleau, V | 1 |
| Penfornis, A | 1 |
| Pradignac, A | 1 |
| Ovize, M | 1 |
| Sdringola, S | 1 |
| Johnson, NP | 1 |
| Kirkeeide, RL | 1 |
| Cid, E | 1 |
| Gould, KL | 1 |
| Gewirtz, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Strategy Trial Comparing Detection of Silent Ischemia With no Detection of Silent Ischemia in Asymptomatic Patients With Type 2 Diabetes Mellitus. Effects on Cardiovascular Events.[NCT00627783] | 642 participants (Actual) | Interventional | 2000-12-31 | Terminated (stopped due to Poor recruiting status) | |||
| Functional and Anatomic Imaging Versus No Testing in Asymptomatic High-risk Diabetic Patients[NCT04388280] | 400 participants (Anticipated) | Interventional | 2021-01-28 | Recruiting | |||
| Quantification of Myocardial Blood Flow by Positron Emission Tomography in Healthy Volunteers[NCT03895554] | 20 participants (Anticipated) | Observational | 2019-04-01 | Not yet recruiting | |||
| Ammonia N-13 Myocardial Blood Flow Absolute Quantification by Positron Emission Tomography in Patients With Known or Suspected Coronary Artery Disease (Ammonia MAP)[NCT04343209] | 2,500 participants (Anticipated) | Observational | 2020-09-14 | Recruiting | |||
| Quantification of Myocardial Blood Flow by 3D Positron Emission Tomography With High and Low Rate Rb82 Infusion Profiles[NCT05286593] | Phase 4 | 98 participants (Actual) | Interventional | 2021-12-28 | Completed | ||
| The Impact of Coronary Revascularization on Absolute Myocardial Blood Flow as Assessed by Stress Myocardial Positron Tomography[NCT02931331] | 50 participants (Anticipated) | Observational [Patient Registry] | 2016-03-31 | Enrolling by invitation | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for dipyridamole and Asymptomatic Conditions
1 trial available for dipyridamole and Asymptomatic Conditions
4 other studies available for dipyridamole and Asymptomatic Conditions
| Article | Year |
|---|---|
Prognostic value of stress cardiovascular magnetic resonance in asymptomatic patients with known coronary artery disease.
Topics: Aged; Asymptomatic Diseases; Coronary Artery Disease; Dipyridamole; Disease Progression; Female; Hum | 2021 |
Predictors of silent myocardial ischemia in resistant hypertensive patients.
Topics: Adult; Aged; Albuminuria; Antihypertensive Agents; Asymptomatic Diseases; Blood Pressure; Blood Pres | 2015 |
Impact of unexpected factors on quantitative myocardial perfusion and coronary flow reserve in young, asymptomatic volunteers.
Topics: Adult; Age Factors; Asymptomatic Diseases; Cardiovascular Diseases; Chi-Square Distribution; Coronar | 2011 |
Impact of unexpected factors on quantitative myocardial perfusion and coronary flow reserve in young, asymptomatic volunteers.
Topics: Adult; Age Factors; Asymptomatic Diseases; Cardiovascular Diseases; Chi-Square Distribution; Coronar | 2011 |
Impact of unexpected factors on quantitative myocardial perfusion and coronary flow reserve in young, asymptomatic volunteers.
Topics: Adult; Age Factors; Asymptomatic Diseases; Cardiovascular Diseases; Chi-Square Distribution; Coronar | 2011 |
Impact of unexpected factors on quantitative myocardial perfusion and coronary flow reserve in young, asymptomatic volunteers.
Topics: Adult; Age Factors; Asymptomatic Diseases; Cardiovascular Diseases; Chi-Square Distribution; Coronar | 2011 |
Impact of unexpected factors on quantitative myocardial perfusion and coronary flow reserve in young, asymptomatic volunteers.
Topics: Adult; Age Factors; Asymptomatic Diseases; Cardiovascular Diseases; Chi-Square Distribution; Coronar | 2011 |
Impact of unexpected factors on quantitative myocardial perfusion and coronary flow reserve in young, asymptomatic volunteers.
Topics: Adult; Age Factors; Asymptomatic Diseases; Cardiovascular Diseases; Chi-Square Distribution; Coronar | 2011 |
Impact of unexpected factors on quantitative myocardial perfusion and coronary flow reserve in young, asymptomatic volunteers.
Topics: Adult; Age Factors; Asymptomatic Diseases; Cardiovascular Diseases; Chi-Square Distribution; Coronar | 2011 |
Impact of unexpected factors on quantitative myocardial perfusion and coronary flow reserve in young, asymptomatic volunteers.
Topics: Adult; Age Factors; Asymptomatic Diseases; Cardiovascular Diseases; Chi-Square Distribution; Coronar | 2011 |
Impact of unexpected factors on quantitative myocardial perfusion and coronary flow reserve in young, asymptomatic volunteers.
Topics: Adult; Age Factors; Asymptomatic Diseases; Cardiovascular Diseases; Chi-Square Distribution; Coronar | 2011 |
Impact of unexpected factors on quantitative myocardial perfusion and coronary flow reserve in young, asymptomatic volunteers.
Topics: Adult; Age Factors; Asymptomatic Diseases; Cardiovascular Diseases; Chi-Square Distribution; Coronar | 2011 |
Impact of unexpected factors on quantitative myocardial perfusion and coronary flow reserve in young, asymptomatic volunteers.
Topics: Adult; Age Factors; Asymptomatic Diseases; Cardiovascular Diseases; Chi-Square Distribution; Coronar | 2011 |
Impact of unexpected factors on quantitative myocardial perfusion and coronary flow reserve in young, asymptomatic volunteers.
Topics: Adult; Age Factors; Asymptomatic Diseases; Cardiovascular Diseases; Chi-Square Distribution; Coronar | 2011 |
Impact of unexpected factors on quantitative myocardial perfusion and coronary flow reserve in young, asymptomatic volunteers.
Topics: Adult; Age Factors; Asymptomatic Diseases; Cardiovascular Diseases; Chi-Square Distribution; Coronar | 2011 |
Impact of unexpected factors on quantitative myocardial perfusion and coronary flow reserve in young, asymptomatic volunteers.
Topics: Adult; Age Factors; Asymptomatic Diseases; Cardiovascular Diseases; Chi-Square Distribution; Coronar | 2011 |
Impact of unexpected factors on quantitative myocardial perfusion and coronary flow reserve in young, asymptomatic volunteers.
Topics: Adult; Age Factors; Asymptomatic Diseases; Cardiovascular Diseases; Chi-Square Distribution; Coronar | 2011 |
Impact of unexpected factors on quantitative myocardial perfusion and coronary flow reserve in young, asymptomatic volunteers.
Topics: Adult; Age Factors; Asymptomatic Diseases; Cardiovascular Diseases; Chi-Square Distribution; Coronar | 2011 |
Quantitative PET measurements of myocardial blood flow in young, healthy volunteers what should we expect?
Topics: Adult; Age Factors; Asymptomatic Diseases; Cardiovascular Diseases; Coronary Circulation; Dipyridamo | 2011 |